2024 (full bibliographic detail under MA verification)
Rahman adds, Obesity and overweight are highly prevalent conditions associated with considerable morbidity and mortality, and successful weight loss interventions can lead to important reductions in cardiometabolic risk. Though semaglutide can lead to meaningful weight loss in some individuals, it comes with important risks and limitations
While this may not be applicable to all patients, for those who have achieved sufficient weight loss, gradually extending the injection interval is a promising strategy to reduce the burden while maintaining the effects, the research team stated
This approach is particularly effective when excess body weight and visceral fat are primary contributors to elevated triglycerides
Long COVID has had devastating effects for the 1.4 million Canadians that are currently or have experienced the syndrome
However, tirzepatide may cause more nausea initially, while semaglutide users often report more persistent digestive discomfort
